Tatva Chintan Pharma Chem Limited

NSE:TATVA.NS

856.35 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017
Operating Activities:
Net Income 303.54447.791,041.21606.96475.97273.93122.89
Depreciation & Amortization 256.0595.5581.867.3247.9340.1829.52
Deferred Income Tax 0000000
Stock Based Compensation 0000000
Change In Working Capital 357.33-284.15-753.71-377.76-226.44-216.59-0.66
Accounts Receivables 112.48-314.4322.99-419.3-83.13-125.16-84.06
Inventory 97.3274.59-979.39-84.63-279.64-67.72-29.78
Accounts Payables 153.85-126.56-30.63158.6494.77-25.6863.19
Other Working Capital -6.3282.22-66.68-32.4741.561.9749.99
Other Non Cash Items 179.3918.64-165.52-53.33-44.34-23.9662.06
Operating Cash Flow 947.86277.83203.78243.19253.1273.56104.12
Investing Activities:
Investments In Property Plant And Equipment -1,285.15-2,031.1-891.57-209.7-481.72-97.86-304.61
Acquisitions Net 1.550.680.780.190.2772.030.61
Purchases Of Investments -99-967.42-1,122.66-0.19-0.27-77.340
Sales Maturities Of Investments 144.46966.741,121.882.4974.485.310.08
Other Investing Activites 79.751,019.67-1,076.49-2.855.44-69.842.96
Investing Cash Flow -1,238.14-1,011.43-1,968.06-210.06-401.8-167.7-303.92
Financing Activities:
Debt Repayment -1,547.98-139.37-135.28-183.99-87.15-66.29-97.64
Common Stock Issued 1,965.9602,111.040000
Common Stock Repurchased 0000000
Dividends Paid -46.78-44.330-40.18000
Other Financing Activities -0.69561.65373.88136.16186.67240.28-0.2
Financing Cash Flow 370.51377.952,349.64-88.0199.52173.9997.44
Other Information:
Effect Of Forex Changes On Cash -0.84-0.86-0.18-8.600179.96
Net Change In Cash 73.81-356.51585.36-54.88-49.1679.8577.6
Cash At End Of Period 382.92273.66630.1753.41108.29157.4577.6